ES2085337T3 - Comprimidos farmaceuticos. - Google Patents

Comprimidos farmaceuticos.

Info

Publication number
ES2085337T3
ES2085337T3 ES90313178T ES90313178T ES2085337T3 ES 2085337 T3 ES2085337 T3 ES 2085337T3 ES 90313178 T ES90313178 T ES 90313178T ES 90313178 T ES90313178 T ES 90313178T ES 2085337 T3 ES2085337 T3 ES 2085337T3
Authority
ES
Spain
Prior art keywords
pharmaceutical tablets
dragons
dissolutions
slow
driver
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90313178T
Other languages
English (en)
Inventor
David George Sixsmith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis UK Holdings Ltd
Original Assignee
Marion Merrell Dow Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marion Merrell Dow Ltd filed Critical Marion Merrell Dow Ltd
Application granted granted Critical
Publication of ES2085337T3 publication Critical patent/ES2085337T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)

Abstract

UN ALCOHOL POLIHIDRICO TRATADO CON GELATINA ES ADECUADO, COMO UN CONDUCTOR DE AGENTES MEDICINALES, EN ESPECIAL EN FORMA DE GRAGEAS, PARA DISOLUCIONES LENTAS POR VIA ORAL.
ES90313178T 1989-12-13 1990-12-05 Comprimidos farmaceuticos. Expired - Lifetime ES2085337T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928196A GB8928196D0 (en) 1989-12-13 1989-12-13 Pharmaceutical lozenges

Publications (1)

Publication Number Publication Date
ES2085337T3 true ES2085337T3 (es) 1996-06-01

Family

ID=10667903

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90313178T Expired - Lifetime ES2085337T3 (es) 1989-12-13 1990-12-05 Comprimidos farmaceuticos.

Country Status (14)

Country Link
US (1) US5322694A (es)
EP (1) EP0432956B1 (es)
JP (1) JPH04208218A (es)
KR (1) KR0184640B1 (es)
AT (1) ATE133563T1 (es)
AU (1) AU634609B2 (es)
CA (1) CA2032068C (es)
DE (1) DE69025150T2 (es)
DK (1) DK0432956T3 (es)
ES (1) ES2085337T3 (es)
GB (1) GB8928196D0 (es)
GR (1) GR3018865T3 (es)
IE (1) IE75218B1 (es)
NZ (1) NZ236415A (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
US6183775B1 (en) * 1996-05-13 2001-02-06 Novartis Consumer Health S.A. Buccal delivery system
US5846568A (en) * 1996-09-19 1998-12-08 Xyrofin Oy Directly compressible lactitol and method
IT1297233B1 (it) * 1996-10-29 1999-08-09 Montefarmaco Spa Composizioni farmaceutiche solide in forma di caramelle contenenti disinfettanti e sostanze mucoadesive per una disinfezione topica
US6432442B1 (en) * 1998-02-23 2002-08-13 Mcneil-Ppc, Inc. Chewable product
US8758400B2 (en) 2000-01-05 2014-06-24 Integrated Vascular Systems, Inc. Closure system and methods of use
JP2004508092A (ja) 2000-09-08 2004-03-18 コールマン　ジェイムス　イー 外科用ステープラ
US6623510B2 (en) 2000-12-07 2003-09-23 Integrated Vascular Systems, Inc. Closure device and methods for making and using them
US8690910B2 (en) 2000-12-07 2014-04-08 Integrated Vascular Systems, Inc. Closure device and methods for making and using them
US6749621B2 (en) 2002-02-21 2004-06-15 Integrated Vascular Systems, Inc. Sheath apparatus and methods for delivering a closure device
CA2488688A1 (en) 2002-06-04 2003-12-11 Christy Cummins Blood vessel closure clip and delivery device
US8398656B2 (en) 2003-01-30 2013-03-19 Integrated Vascular Systems, Inc. Clip applier and methods of use
US8202293B2 (en) 2003-01-30 2012-06-19 Integrated Vascular Systems, Inc. Clip applier and methods of use
US20070092552A1 (en) * 2003-04-30 2007-04-26 Tim Clarot Chewable lozenge cold remedy composition and method for making same
US20050152972A1 (en) * 2004-01-14 2005-07-14 Mohinder Singh Soft chewable anesthetic lozenges
US20060288462A1 (en) * 2005-06-22 2006-12-28 Yvonne Schroeder Garments composed of fabric panels incorporating edible cells
US8313497B2 (en) 2005-07-01 2012-11-20 Abbott Laboratories Clip applier and methods of use
US8556930B2 (en) 2006-06-28 2013-10-15 Abbott Laboratories Vessel closure device
US9282965B2 (en) 2008-05-16 2016-03-15 Abbott Laboratories Apparatus and methods for engaging tissue
US9241696B2 (en) 2008-10-30 2016-01-26 Abbott Vascular Inc. Closure device
US9173644B2 (en) 2009-01-09 2015-11-03 Abbott Vascular Inc. Closure devices, systems, and methods
US9486191B2 (en) 2009-01-09 2016-11-08 Abbott Vascular, Inc. Closure devices
US9414820B2 (en) 2009-01-09 2016-08-16 Abbott Vascular Inc. Closure devices, systems, and methods
US20100179589A1 (en) * 2009-01-09 2010-07-15 Abbott Vascular Inc. Rapidly eroding anchor
US20100185234A1 (en) 2009-01-16 2010-07-22 Abbott Vascular Inc. Closure devices, systems, and methods
US20110054492A1 (en) 2009-08-26 2011-03-03 Abbott Laboratories Medical device for repairing a fistula
LT3284459T (lt) 2011-04-29 2021-04-12 Moberg Pharma Ab Farmacinės kompozicijos, apimančios vietinį anestetiką, tokį kaip bupivakainas, skirtos vietiniam įvedimui į burną arba gerklę
US9332976B2 (en) 2011-11-30 2016-05-10 Abbott Cardiovascular Systems, Inc. Tissue closure device
US9364209B2 (en) 2012-12-21 2016-06-14 Abbott Cardiovascular Systems, Inc. Articulating suturing device
DK3003285T3 (en) * 2013-06-03 2022-04-04 Mcneil Ab Fast farmaceutisk dosisform til frigivelse af mindst to aktive farmaceutiske ingredienser i mundhulen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2009597B (en) * 1977-12-10 1982-06-23 Beecham Group Ltd Antacid compositions
GB2122892B (en) * 1982-07-02 1986-01-29 Squibb & Sons Inc Nystantin pastille formulation
EP0117811A3 (fr) * 1983-02-23 1987-06-03 Sanofi S.A. Compositions pharmaceutiques antifongiques utilisables par voie orale
US4624849A (en) * 1984-11-02 1986-11-25 The Procter & Gamble Company Antimicrobial lozenges
DE3824318A1 (de) * 1988-07-18 1990-01-25 Merck Patent Gmbh Xylit- und zuckerfreie kautablette
JPH0669948B2 (ja) * 1989-07-21 1994-09-07 エスエス製薬株式会社 トローチ剤

Also Published As

Publication number Publication date
GR3018865T3 (en) 1996-05-31
EP0432956A1 (en) 1991-06-19
DK0432956T3 (da) 1996-02-19
EP0432956B1 (en) 1996-01-31
JPH04208218A (ja) 1992-07-29
NZ236415A (en) 1992-10-28
AU634609B2 (en) 1993-02-25
CA2032068A1 (en) 1991-06-14
IE75218B1 (en) 1997-08-27
ATE133563T1 (de) 1996-02-15
KR0184640B1 (ko) 1999-05-01
US5322694A (en) 1994-06-21
CA2032068C (en) 2001-05-15
IE904482A1 (en) 1991-06-19
GB8928196D0 (en) 1990-02-14
DE69025150D1 (de) 1996-03-14
DE69025150T2 (de) 1996-05-30
AU6782990A (en) 1991-06-20
KR910011244A (ko) 1991-08-07

Similar Documents

Publication Publication Date Title
ATE133563T1 (de) Pharmazeutische lutschpastillen
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
DE3783394D1 (de) Arzneizubereitung zur oralen anwendung.
DK152287D0 (da) Farmaceutisk vaginalmiddel
MA23608A1 (fr) Forme de dosage ii d'unite multiple en comprime
ES2165640T3 (es) Acidos diaminocarboxilicos sustituidos.
DE3669104D1 (de) Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten.
DE19975062I1 (de) Pharmazeutische Zusammensetzungen die N-substituierte 3-Hydroxypyrid-2-on-oder-4-on-Derivate enthalten
ATE230993T1 (de) Pharmazeutische zusammensetzung zur behandlung von alkoholabhängigkeit, die opioid antagonisten mit nmda-rezeptorkomplex-modulatoren enthält
PT88138A (pt) Processo para a producao de uma forma de administracao ou de dosagem para substancias medicinais activas por meio de um processo de impressao
FI863971A7 (fi) Farmaseuttinen koostumus käytettäväksi leukopenian hoidossa.
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
ATE97001T1 (de) Topisch anzuwendende defibrotid enthaltende arzneizubereitungen.
HUT62471A (en) Process for producing pharmaceutical compositions comprising ipriflavone
ITMI912071A1 (it) Forme farmaceutiche antivirali per applicazione vaginale
IT8722501A0 (it) Formulazioni farmaceutiche per somministrazione transdermica.
KR900007816A (ko) 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도
IT8619382A0 (it) Composizioni farmaceutiche per la terapia di cerebropatie su base organica e funzionale.
ES2043736T3 (es) Acidos 3,5-dihidroxi-heptanoicos sustituidos con (1h-pirrol-3-ilo) en posicion 7, sus correspondientes delta-lactonas y sales, procedimientos para su preparacion, su utilizacion como medicamentos, preparados farmaceuticos y productos intermedios.
ATA133288A (de) Pharmazeutische zusammensetzung
SE9003902D0 (sv) Solid dosage forms of a drug
ATE106883T1 (de) Azelastin-embonat, verfahren zu seiner herstellung und pharmazeutische zubereitungen, die als wirkstoff azelastin-embonat enthalten.
IT8722647A0 (it) Composizione farmaceutica per somministrazione nasale.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 432956

Country of ref document: ES